Precision Drilling Corporation (PDS)
Precision Drilling: Oilfield Activity In Canada Appears Resilient, So Far
Oil drilling activity in the U.S. will be cut back due to low prices. However, drilling in Canada is robust due to structural factors, at least for now. Precision Drilling gets 2/3 of its revenue from Canada and may weather the downturn better than its U.S. focused competitors.
EMV Capital portfolio company PDS Biotech advances cancer trial
PDS Biotechnology Corporation (NASDAQ:PDSB), a US cancer immunotherapy firm backed by EMV Capital (AIM:EMVC), has begun site activations for its phase III trial of Versamune HPV in patients with head and neck cancers linked to HPV16. The trial, which will enrol around 350 patients, is supported by the US Food and Drug Administration Fast Track designation and includes interim data readouts.
Precision Drilling Corporation (PDS) Q1 2025 Earnings Call Transcript
Precision Drilling Corporation (NYSE:PDS ) Q1 2025 Earnings Conference Call April 24, 2025 1:00 PM ET Company Participants Lavonne Zdunich - Vice President of Investor Relations Carey Ford - Chief Financial Officer Kevin Neveu - President, Chief Executive Officer & Director Conference Call Participants Aaron MacNeil - TD Cowen Keith MacKey - RBC Capital Markets Waqar Syed - ATB Capital Markets John Gibson - BMO Capital Markets John Daniel - Daniel Energy Partners Aaron Rosenthal - JPMorgan Operator Good day and thank you for standing by. Welcome to the Precision Drilling Corporation 2025 First Quarter Results Conference Call and Webcast.
Precision Drilling (PDS) Misses Q1 Earnings and Revenue Estimates
Precision Drilling (PDS) came out with quarterly earnings of $1.53 per share, missing the Zacks Consensus Estimate of $1.57 per share. This compares to earnings of $1.88 per share a year ago.
Earnings Preview: Precision Drilling (PDS) Q1 Earnings Expected to Decline
Precision Drilling (PDS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
EMV Capital portfolio company PDS Biotechnology raises $11mln
EMV Capital plc (AIM: EMVC) portfolio company PDS Biotechnology Corporation (Nasdaq: PDSB) has raised $11 million, through an equity funding. PDS, which is focussed on immunotherapies, sold around 7.33 million new shares in a direct offer, plus warrants which (if exercised) will bring in another $11 million.
Precision Drilling: Accelerating Capital Returns Should Put A Floor On The Stock
Precision Drilling Corporation underwhelmed in its Q4-2024 report. The company did deliver on its debt reduction target and cash flow should start flowing increasingly in the direction of shareholders. We go over the numbers and tell you how we are playing this.
Precision Drilling Corporation (PDS) Q4 2024 Earnings Call Transcript
Precision Drilling Corporation (NYSE:PDS ) Q4 2024 Earnings Conference Call February 13, 2025 1:00 PM ET Company Participants Lavonne Zdunich - VP, Investor Relations Carey Ford - CFO Kevin Neveu - President, CEO & Director Conference Call Participants Aaron MacNeil - TD Cowen Kurt Hallead - Benchmark Sean Mitchell - Daniel Energy Partners Keith MacKey - RBC Capital Markets Waqar Syed - ATB Capital Markets Operator Good day, and thank you for standing by. Welcome to the Precision Drilling Corporation 2024 Fourth Quarter and End of Year Results Conference Call and Webcast.
Precision Drilling (PDS) Misses Q4 Earnings and Revenue Estimates
Precision Drilling (PDS) came out with quarterly earnings of $0.76 per share, missing the Zacks Consensus Estimate of $1.40 per share. This compares to earnings of $3.45 per share a year ago.
Precision Drilling: Capitalizing On Strong Activity In Canada
Precision Drilling's Q3 report shows strong performance in Canada, where rig demand is at multiyear highs. While the U.S. market remains a weakness, Precision Drilling is generating adequate margins on its super spec rigs that remain in tight supply. When U.S. activity rebounds, Precision Drilling will benefit from the much higher pricing that will be necessary to balance the market.
EMV Capital highlights progress update from portfolio company PDS Biotech
EMV Capital (AIM:EMVC) has noted the clinical progress update from portfolio company PDS Biotechnology alongside its third-quarter update. Frank Bedu-Addo, PDS chief executive, said: "Since our last update in August, we have been actively engaged with investors and clinicians to discuss our strategy and funding requirements for our VERSATILE-003 Phase 3 trial of Versamune® HPV + pembrolizumab compared to pembrolizumab as a potential treatment for first-line recurrent/metastatic HPV16-positive head and neck squamous cell cancer (HNSCC).
Precision Drilling Corporation (PDS) Q3 2024 Earnings Conference Call Transcript
Precision Drilling Corporation (NYSE:PDS ) Q3 2024 Earnings Conference Call October 30, 2024 1:00 PM ET Company Participants Lavonne Zdunich - VP, IR Carey Ford - CFO Kevin Neveu - President and CEO Conference Call Participants Kurt Hallead - Benchmark Waqar Syed - ATB Capital Markets Sean Mitchell - Daniel Energy Partners John Gibson - BMO Capital Markets Keith Mackey - RBC Capital Markets Aaron MacNeil - TD Cowen Operator Good day, and thank you for standing by. Welcome to the Precision Drilling Corporation 2024 Third Quarter Conference Call.
